Skip to Main Content

Paper Details

Identifying the Lipidomic Effects of a Rare Loss-of-Function Deletion in .
Circulation. Genomic and precision medicine
2
2021
ANGPTL3, ANGPTL3 gene, ANGPTL3 protein, Loss-of-Function Deletion, angiopoietin-like 3, atherosclerotic cardiovascular disease, chromosome 1, endothelial and lipoprotein lipase, levels and, loss-of-function variants, plasma, rs398122988
Author NameAffiliation
Juan M PeraltaSouth Texas Diabetes and Obesity Institute (N.B.B., The University of Texas Rio Grande Valley
Juan M PeraltaThe University of Texas Rio Grande Valley
Juan M PeraltaMenzies Institute for Medical Research, University of Tasmania
Satish KumarSouth Texas Diabetes and Obesity Institute (N.B.B., The University of Texas Rio Grande Valley
Satish KumarThe University of Texas Rio Grande Valley
David C GlahnBoston Children's Hospital and Harvard Medical School
David C GlahnOlin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital
Ravindranath DuggiralaSouth Texas Diabetes and Obesity Institute (N.B.B., The University of Texas Rio Grande Valley
Ravindranath DuggiralaThe University of Texas Rio Grande Valley
John BlangeroSouth Texas Diabetes and Obesity Institute (N.B.B., The University of Texas Rio Grande Valley
John BlangeroThe University of Texas Rio Grande Valley
Joanne E CurranSouth Texas Diabetes and Obesity Institute (N.B.B., The University of Texas Rio Grande Valley
Joanne E CurranThe University of Texas Rio Grande Valley
  • 1 - 13

Datasets

Release 1.2